221 related articles for article (PubMed ID: 17631566)
1. Targeted therapies in lung cancer.
Besse B; Ropert S; Soria JC
Ann Oncol; 2007 Jul; 18 Suppl 9():ix135-42. PubMed ID: 17631566
[No Abstract] [Full Text] [Related]
2. Antiangiogenic agents.
Stani SC; Capaccetti B; Bonginelli P; Sarmiento R; De Sio L; Fanelli M; Gasparini G
Suppl Tumori; 2002; 1(4):S39-43. PubMed ID: 12415816
[No Abstract] [Full Text] [Related]
3. Multitargeted anti-angiogenic agents and NSCLC: clinical update and future directions.
Ellis PM; Al-Saleh K
Crit Rev Oncol Hematol; 2012 Oct; 84(1):47-58. PubMed ID: 22405734
[TBL] [Abstract][Full Text] [Related]
4. Nintedanib for the treatment of non-small-cell lung cancer.
Rashdan S; Hanna N
Expert Opin Pharmacother; 2014 Apr; 15(5):729-39. PubMed ID: 24597846
[TBL] [Abstract][Full Text] [Related]
5. [Angiogenesis and neoangiogenesis--the role in lung cancer and other tumors].
Swidzińska E; Naumnik W; Chyczewska E
Pneumonol Alergol Pol; 2006; 74(4):414-20. PubMed ID: 17427152
[No Abstract] [Full Text] [Related]
6. [Responses to targeted therapies: lung cancer].
Brambilla E
Ann Pathol; 2009 Nov; 29 Spec No 1():S77-80. PubMed ID: 19887261
[No Abstract] [Full Text] [Related]
7. Targeting angiogenesis in advanced non-small cell lung cancer.
Lammers PE; Horn L
J Natl Compr Canc Netw; 2013 Oct; 11(10):1235-47. PubMed ID: 24142825
[TBL] [Abstract][Full Text] [Related]
8. Targeted cancer therapies.
Blay JY; Le Cesne A; Alberti L; Ray-Coquart I
Bull Cancer; 2005 Feb; 92(2):E13-8. PubMed ID: 15749638
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapies in non-small cell lung cancer: proven concepts and unfulfilled promises.
Auberger J; Loeffler-Ragg J; Wurzer W; Hilbe W
Curr Cancer Drug Targets; 2006 Jun; 6(4):271-94. PubMed ID: 16848720
[TBL] [Abstract][Full Text] [Related]
10. Developing targeted therapies for lung cancer.
Gandara DR
Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
[No Abstract] [Full Text] [Related]
11. Cancer: Limitations of therapies exposed.
Casanovas O
Nature; 2012 Apr; 484(7392):44-6. PubMed ID: 22481354
[No Abstract] [Full Text] [Related]
12. Targeting tumor neovasculature in non-small-cell lung cancer.
Pallis AG; Syrigos KN
Crit Rev Oncol Hematol; 2013 May; 86(2):130-42. PubMed ID: 23159217
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic therapy in nonsmall cell lung cancer.
Gutierrez M; Giaccone G
Curr Opin Oncol; 2008 Mar; 20(2):176-82. PubMed ID: 18300767
[TBL] [Abstract][Full Text] [Related]
14. Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancer.
Toschi L; Cappuzzo F; Jänne PA
Ann Oncol; 2007 Jul; 18 Suppl 9():ix150-5. PubMed ID: 17631569
[No Abstract] [Full Text] [Related]
15. Anti-Angiogenics: Their Value in Lung Cancer Therapy.
Janning M; Loges S
Oncol Res Treat; 2018; 41(4):172-180. PubMed ID: 29631257
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Langer CJ; Natale RB
Semin Oncol; 2005 Dec; 32(6 Suppl 10):S23-9. PubMed ID: 16459176
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor receptor inhibitors for non-small cell lung cancer: is the odyssey over?
Carbognin L; Pilotto S; Peretti U; Tortora G; Bria E
Expert Opin Investig Drugs; 2016 Jun; 25(6):635-8. PubMed ID: 27054716
[No Abstract] [Full Text] [Related]
18. Inhibition of angiogenesis in the treatment of non-small cell lung cancer.
Keedy VL; Sandler AB
Cancer Sci; 2007 Dec; 98(12):1825-30. PubMed ID: 17892508
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis inhibitors.
Das M; Wakelee H
J Thorac Oncol; 2011 Nov; 6(11 Suppl 4):S1801-2. PubMed ID: 22005536
[No Abstract] [Full Text] [Related]
20. Targeted therapies for advanced non-small-cell lung cancer: current status and future implications.
Custodio A; Méndez M; Provencio M
Cancer Treat Rev; 2012 Feb; 38(1):36-53. PubMed ID: 21592673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
